EA2197
OPEN TO ACCRUAL
A Randomized Phase II/III Trial With Optimal Perioperative Therapy For Incidental Gallbladder Cancer
NCI10276
OPEN TO ACCRUAL
Ph1/2 Avelumab +/- M3814 w/ Hypofractionated XRT in Adv/Met Solid Tumors/HPB
UW23046
OPEN TO ACCRUAL
P2 Gem, Cis, AB680 & AB122 for 1st line Tx of Advanced Biliary Tract Cancer